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LETTERS
Dengue Virus 
Type 3 Infection in 
Traveler Returning 
from West Africa
To the Editor: GeoSentinel, the 
global surveillance program of the 
International Society of Travel Medi-
cine, recently reported that returning 
travelers may serve as sentinels for 
local outbreaks of dengue fever in 
tropical areas to which it is endemic 
(1). We investigated a case of dengue 
virus (DENV) type 3 (DENV-3) infec-
tion in a traveler returning to France 
from West Africa, which provided evi-
dence for DENV-3 circulation in Côte 
d’Ivoire.
A 53-year-old French expatriate 
living in Abidjan, the economic capi-
tal of Côte d’Ivoire, arrived in France 
on July 17, 2008, and was hospitalized 
4 days later with fever of 40°C, head-
ache, asthenia, anorexia, chills, diffuse 
arthralgia, and myalgia. Results of a 
physical examination were normal ex-
cept for a diffuse nonpetechial macular 
rash and moderate hepatosplenomega-
ly. A tourniquet test was not performed. 
At admission, platelet count was 103 
cells/mm3 and leukocyte count was 
2,410 cells/mm3. Thin and thick blood 
smears and results of the immunochro-
matographic test (Binax NOW malaria 
tests; Binax, Portland, ME, USA) were 
negative. The patient recovered with-
out sequelae and was discharged 6 
days after admission.
At admission, chikungunya vi-
rus–speciﬁ   c immunoglobulin (Ig) G 
and IgM were not detected by indirect 
immunoﬂ   uorescence tests (2). IgG, 
but not IgM, speciﬁ  c for DENV was 
detected by an immunochromatic test 
(Panbio Dengue Duo Cassette; Bi-
otrin, Lyon, France) and conﬁ  rmed 
by ELISA (PanBio dengue duo test). 
However, DENV RNA was demon-
strated in serum by using 4 reverse-
transcription–PCR (RT-PCR)–based 
assays: a positive result in a ﬂ  avivirus 
universal assay (3), a positive result in 
a DENV-1–4 real-time RT-PCR (4), a 
positive result in a DENV-3–speciﬁ  c 
RT-PCR, and a negative result in a 
speciﬁ  c RT-PCR for DENV-1, -2, and 
-4 (4). The concomitant ﬁ  nding  of 
DENV RNA and IgG against DENV 
suggests the patient had dengue infec-
tion before this episode.
DENV-3 viremia was conﬁ  rmed 
by sequencing a 547-nt region of the 
envelope gene (GenBank accession 
no. FJ587232, nt 852–1398 referring 
to the H87 DENV-3 prototype strain). 
Our sequence aligned with homolo-
gous DENV-3 sequences retrieved 
from GenBank and used for phyloge-
netic analysis (Figure). Our patient, in 
whom classic dengue fever was diag-
nosed, was infected with a strain that 
belonged to genotype III most closely 
related to strains isolated in Singa-
pore, Taiwan, Sri Lanka, India, and 
Saudi Arabia. Its closest relatives were 
the strain from Saudi Arabia isolated 
in 2004 and another strain claimed 
in ProMED by Japanese researchers 
to have been isolated in 2008 from a 
Japanese traveler returning from Côte 
d’Ivoire (6). Therefore, this strain is 
likely to have originated in the Mid-
dle East, the Indian subcontinent, or 
Southeast Asia rather than in Central 
or South America.
In Africa, most data on epidemic 
or endemic dengue activity originate 
in East Africa. Dengue fever was sel-
dom reported in West Africa. In 2000, 
DENV-1 was isolated from a French 
soldier in Côte d’Ivoire (7). More re-
cently, an outbreak caused by DENV-2 
occurred in Gabon in West Africa 
(8). In this context, it is notable that 
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Figure. Phylogenetic analysis of selected dengue virus type 3 (DENV-3) sequences. The 
main genotypes are indicated using roman numerals at the node of the lineage. Sequence 
identiﬁ  cation is as follows: country of origin, strain name, year of isolation/detection. The 
sequence determined in our study is underlined and designated by an arrow. Phylogenetic 
studies were conducted by using MEGA version 2.1 (5). Genetic distances were calculated 
with the Kimura 2-parameter method at the nucleotide level. Phylogenetic trees were 
constructed using the neighbor-joining method. The robustness of the nodes was tested 
by 500 bootstrap replications. The tree was rooted with DENV-1, DENV-2, and DENV-4 
sequences. Scale bar indicates nucleotide substitutions per site.LETTERS
DENV-3 strains recently caused un-
expected outbreaks of dengue hemor-
rhagic fever in Sri Lanka, East Africa, 
and Latin America (9).
The case presented here demon-
strates that epidemics may be unde-
tected or unidentiﬁ  ed until diagnosis 
is assessed in another country from a 
returning infected visitor, thus draw-
ing attention to an unidentiﬁ  ed poten-
tial epidemic situation. This situation 
can be unraveled by a clinician who 
considers geographic factors in the 
diagnostic workup and has access to 
and uses appropriate laboratory capac-
ity to diagnose imported infections. 
At the time dengue was diagnosed 
in this patient, cases of yellow fever 
were reported in the same location of 
Côte d’Ivoire (Abidjan) (5), illustrat-
ing concomitant circulation of 2 vi-
ruses in which dengue may have re-
mained undetected in the absence of a 
laboratory-conﬁ  rmed case in the trav-
eler’s home country. Therefore, this 
case reinforces the utility of travelers 
as sentinels for infectious diseases as 
previously reported (10). Our ﬁ  nd-
ings reiterate the need for technologic 
transfer of PCR-based direct diagnos-
tics to reference centers in areas where 
emergence is likely. These efforts also 
should embrace serology and encour-
age close collaboration with world 
reference centers for conﬁ  rmation and 
characterization (10).
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Low Immunity to 
Measles and Rubella 
among Female 
Guest Workers, 
Northern Mariana 
Islands
To the Editor: The Common-
wealth of the Northern Mariana Is-
lands (CNMI), a group of northern Pa-
ciﬁ  c islands in political union with the 
United States, was exempt from US 
labor laws until 2007. This exemption 
attracted business opportunities, which 
led to a high demand for guest work-
ers. The Centers for Disease Control 
and Prevention advises the US Citi-
zenship and Immigration Services of 
vaccination requirements for those ap-
plying for immigration and work visas 
before the applications are approved 
(1). Since 1996, all applicants born af-
ter 1957 and >12 months of age have 
been required to provide evidence of 
completed vaccination against, or of 
immunity to, measles, mumps, and ru-
bella viruses. Those unable to provide 
such evidence must receive at least 1 
dose of the vaccines recommended by 
the US Advisory Committee on Im-
munization Practices before visa ap-
proval. The Committee also advises 
applicants to receive additional doses 
of the required vaccines after arrival in 
the Mariana Islands. We aimed to de-
termine the proportion of CNMI guest 
workers who were immune to measles 
and rubella by testing a convenience 
sample of serum collected during Sep-
tember and October 2006. However, 
procedures for validating the vaccina-
tion status for our sample population 
are unknown. Given our results, it 
appears that validation procedures of 
immunity status in guest workers or 
immigrants to the United States were 
suboptimal at the time of this study.
Serum samples from 210 female 
workers from 17 through 51 years of 
age were collected opportunistically 
when, as a requirement for annual con-
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